“لايفيرا أوميكس” تعيّن خبير الجينوم الكريّع رئيساً للقسم الطبي والجينومي
“لايفيرا أوميكس” تعيّن خبير الجينوم الكريّع رئيساً للقسم الطبي والجينومي
10 sept. 2024 05h48 HE | Lifera
لايفيرا أوميكس تستهدف تعزيز مكانة المملكة عالمياً في مجال الجينوم البشري متعدد الجينات.لايفيرا، المملوكة بالكامل لصندوق الاستثمارات العامة، توسع نطاق عملياتها في لايفيرا أوميكس، وتستثمر في بناء فريق...
Lifera Omics Appoints Prof. Fowzan Alkuraya, a Renowned Genomics Expert as Chief Medical and Genomic Officer
Lifera Omics Appoints Prof. Fowzan Alkuraya, a Renowned Genomics Expert as Chief Medical and Genomic Officer
10 sept. 2024 05h48 HE | Lifera
Lifera Omics Chief Medical and Genomics Hiring Announcement
Centogene_Logo.png
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
28 nov. 2023 06h30 HE | Centogene NV
Lifera Omics, newly formed Joint Venture (JV) to be based in Riyadh, Saudi Arabia, provides state-of-the-art genomic and multiomic testing services to patients, health systems, biopharma clients, and...
Centogene_Logo.png
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment
27 juin 2023 07h30 HE | Centogene NV
Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) based in RiyadhJV...